These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 25891367)
1. Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line. Han S; Lv X; Wang Y; Gong H; Zhang C; Tong A; Zhang B; Yao H Mol Med Rep; 2015 Aug; 12(2):2239-46. PubMed ID: 25891367 [TBL] [Abstract][Full Text] [Related]
2. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Wang Y; Niu XL; Qu Y; Wu J; Zhu YQ; Sun WJ; Li LZ Cancer Lett; 2010 Sep; 295(1):110-23. PubMed ID: 20236757 [TBL] [Abstract][Full Text] [Related]
3. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism. Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252 [TBL] [Abstract][Full Text] [Related]
4. Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line. Zhang K; Wang X; Wang H Mol Med Rep; 2014 Oct; 10(4):2065-72. PubMed ID: 25109654 [TBL] [Abstract][Full Text] [Related]
5. Effect of microRNA-21 on multidrug resistance reversal in A549/DDP human lung cancer cells. Dong Z; Ren L; Lin L; Li J; Huang Y; Li J Mol Med Rep; 2015 Jan; 11(1):682-90. PubMed ID: 25323306 [TBL] [Abstract][Full Text] [Related]
6. Reversing effect and mechanism of soluble resistance-related calcium-binding protein on multidrug resistance in human lung cancer A549/DDP cells. Gao Y; Li W; Liu X; Gao F; Zhao X Mol Med Rep; 2015 Mar; 11(3):2118-24. PubMed ID: 25394367 [TBL] [Abstract][Full Text] [Related]
8. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress. Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186 [TBL] [Abstract][Full Text] [Related]
9. Cytokine-induced killer cells induce apoptosis and inhibit the Akt/nuclear factor-κB signaling pathway in cisplatin-resistant human glioma U87MG cells. Cui Y; Yang F; He L Mol Med Rep; 2015 Nov; 12(5):7027-32. PubMed ID: 26299434 [TBL] [Abstract][Full Text] [Related]
10. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness. Pavan S; Olivero M; Corà D; Di Renzo MF Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells. Feng R; Dong L Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line. Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826 [TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo. Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122 [TBL] [Abstract][Full Text] [Related]
14. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways. Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949 [TBL] [Abstract][Full Text] [Related]
15. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth. Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072 [TBL] [Abstract][Full Text] [Related]
16. PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line. Tang T; Song X; Liu YF; Wang WY Cell Biol Int; 2014 Apr; 38(4):502-10. PubMed ID: 23956061 [TBL] [Abstract][Full Text] [Related]
17. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines. Xu P; Jiang YF; Wang JH Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737 [TBL] [Abstract][Full Text] [Related]
18. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells. Wong JC; Bathina M; Fiscus RR J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515 [TBL] [Abstract][Full Text] [Related]
19. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway]. Wang LJ; Wang SG; Deng TX Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565 [TBL] [Abstract][Full Text] [Related]
20. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways. Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]